Our results indicate that the R375G TBK1 mutation did not affect the levels of mRNA nor the total TBK1 content, as quantification of the Western blots confirmed similar levels of TBK1 protein in both control- and ALS patient-derived lymphoblasts. The gene discussed is TBK1; the disease is amyotrophic lateral sclerosis.